Angela M Abbott, SLP - Speech-Language Pathologist in Star, ID

Angela M Abbott, SLP is a Speech-language Pathologist based in Star, Idaho. Angela M Abbott is licensed to practice in Idaho (license number SLP-2792) and her current practice location is 79 N Plummer Rd, Star, Idaho. She can be reached at her office (for appointments etc.) via phone at (208) 391-2773.

NPI number for Angela M Abbott is 1275170383 and her current mailing address is 79 N Plummer Rd, Star, Idaho. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1275170383.

Contact Information

Angela M Abbott, SLP
79 N Plummer Rd,
Star, ID 83669-5561
(208) 391-2773
Not Available



Healthcare Provider's Profile

Full NameAngela M Abbott
GenderFemale
SpecialitySpeech-language Pathologist
Location79 N Plummer Rd, Star, Idaho
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1275170383
  • Provider Enumeration Date: 12/09/2019
  • Last Update Date: 12/09/2019

Medical Identifiers

Medical identifiers for Angela M Abbott such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1275170383NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist SLP-2792 (Idaho)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Angela M Abbott is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Angela M Abbott, SLP
79 N Plummer Rd,
Star, ID 83669-5561

Ph: (208) 391-2773
Angela M Abbott, SLP
79 N Plummer Rd,
Star, ID 83669-5561

Ph: (208) 391-2773

News Archive

Immune checkpoint inhibitor as adjuvant therapy improves overall survival in patients with stage III melanoma

Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results presented for the first time today at the ESMO 2016 Congress in Copenhagen.

Scientists to combine NK cell therapy with immunocytokine to target childhood cancer

Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer cells has shown promise as a treatment option to target and kill cancer cells in a less toxic way than conventional therapies. Now for the first time, scientists will combine NK cell therapy with an immunocytokine to target children with relapsed/refractory disease including those with bulky tumors.

Cardiac CT offers a better, cost-effective approach to diagnose low-risk chest pain patients

Using cardiac CT to diagnose low risk patients with chest pain is significantly cheaper - 44% less than the standard of care - and can decrease the length of hospital stay up to 20 hours, according to a study performed at the University of Washington in Seattle, WA.

New book relates mercury in vaccines to autism

The U.S. government revealed last week that they will compensate a family millions of dollars for their daughter's injury related to her infant vaccines that contained mercury and the subsequent development of autism. Yet, the CDC continues to tell the public that there is no connection between vaccines and autism and that the mercury has been removed, although the flu shot recommended for all pregnant women, infants, and children continues to be preserved with mercury.

RNA used to turn on genes to alleviate disease

A new technique that employs RNA, a tiny chemical cousin of DNA, to turn on genes could lead to therapeutics for conditions in which nudging a gene awake would help alleviate disease, researchers at UT Southwestern Medical Center say.

Read more News

› Verified 9 days ago


Speech-Language Pathologist in Star, ID

Jessica Myers, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12222 W Bridger Bay Dr, Star, ID 83669
Phone: 208-391-2773    
Marian Therese Peloquin, MS, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 10979 W Collina Vista Dr, Star, ID 83669
Phone: 805-390-8404    
Kourtney Schaffner, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 7485 Southern Vista Ct, Star, ID 83669
Phone: 208-608-4985    
Paige Elizabeth Casey, M.S
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 11284 W Shortcreek Ct, Star, ID 83669
Phone: 714-932-0633    
Andrea Snow, M.S. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12222 W Bridger Bay Dr, Star, ID 83669
Phone: 208-391-2773    Fax: 855-255-0774
James Everett Collings,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12222 W Bridger Bay Dr, Star, ID 83669
Phone: 208-391-2773    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.